Discontinuations Sample Clauses
The Discontinuations clause defines the conditions and procedures under which a party may cease participation in an agreement or terminate a specific activity or service. Typically, this clause outlines the required notice period, any obligations that must be fulfilled before discontinuation, and the consequences of ending the arrangement, such as final payments or return of materials. Its core practical function is to provide a clear and orderly process for ending involvement, thereby minimizing disputes and ensuring both parties understand their rights and responsibilities upon discontinuation.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the investigator after signing informed consent. Subject numbers of discontinued subjects must not be re-used (i.e., subject replacement is not allowed). Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the investigator, continued treatment poses a risk to their health. For subjects discontinuing from the study, the investigator must complete all Exit procedures according to Table 3-1 Schedule of Study Procedures and Assessments if the subject is willing and able, and if in the opinion of the investigator it is safe for the subject to do so. The investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. Nothing in this Agreement precludes the Corporation from at any time discontinuing the sale of any Product which the Corporation concludes in its sole discretion is no longer profitable or otherwise feasible for the Corporation to sell.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the Investigator after signing the informed consent. Subject numbers of discontinued subjects must not be re-used. Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the Investigator, continued treatment poses a risk to their health.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the investigator after signing the informed consent. Subject numbers of discontinued subjects must not be re-used (i.e., subject replacement is not allowed). Subjects may discontinue from study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the investigator, continued treatment poses a risk to their health. If a subject discontinues from study treatment, every effort must be made to keep the subject in the study and to continue with the study assessments as specified in the schedule of study procedures and assessments until the final visit. For subjects discontinuing from the study, the investigator must complete all Exit procedures according to Table 3-1 Schedule of Study Procedures and Assessments and Section 10.4.3, if the subject is willing and able, and if in the opinion of the investigator it is safe for the subject to do so. The investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. Discontinued subjects are individuals who voluntarily withdraw or are withdrawn from the study by the Investigator after signing the informed consent, including screen failures. Subject numbers of discontinued subjects must not be re-used. Subjects may discontinue from the study or study treatment at any time for any reason. Subjects may also be discontinued from study treatment at any time if, in the opinion of the Investigator, continued treatment poses a risk to their health. For subjects discontinuing from the study, the Investigator must complete all Exit procedures according to Table 3–1, if the subject is willing and able, and if in the opinion of the Investigator it is safe for the subject to do so. The Investigator must document the reason for study or treatment discontinuation in the subject’s case history source documents. To ensure the safety of all subjects who discontinue early, Investigators must assess each subject and, if necessary, advise them of any therapies and/or medical procedures that may be needed to maintain their health.
Discontinuations. Nothing in this Agreement shall preclude Vision X from discontinuing the sale of any Product which Vision X reasonably concludes is no longer profitable or otherwise feasible for Vision X to sell, provided Vision X gives the Reseller at least thirty (30) days prior notice of such discontinuation.
Discontinuations. With 90 days written notice, and subject to Supplier's approval (which will not be unreasonably withheld), Buyer may from time to time discontinue existing SKUs.
Discontinuations. Version: 1.0; CURRENT; Most-Recent; Effective
Discontinuations. The subject is discontinued in the following cases:
1) The investigational lens was removed for reasons of adverse events.
2) The investigator (or sub-investigator) judged it necessary to replace the investigational lens with another IOL.
3) The investigator (or sub-investigator) judged it necessary to discontinue the subject from the study.
4) The subject canceled the consent once issued.
5) The subject requested discontinuation of the study.
6) Continuation of the study was judged as impossible because of subject’s referral or move during the study.
7) Other (discontinuation is necessary) Upon discontinuation of the study, if the investigator or sub-investigator decided the examination or observation is necessary, the examination or observation should be carried out as far as possible under the subject’s consent, and the date and reason of discontinuation are entered in the electric case report form. In case where continuation of the study is difficult because of discontinued visit of the subject to the clinic, the subject is followed over telephone, by mail or other appropriate means and the reason for discontinued visit, survival/death of the subject, presence/absence of adverse events, etc., are entered in the electric case report form. If the investigational lens remained implanted in the subject after discontinuation of the study, the subject is informed as to the necessity of receiving periodical ophthalmological follow-up to assure safety at 30 – 60 days after surgery, and the subject is asked to extent cooperation as much as possible.